Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $186.15 | Total: $930.75 |
| 1 | 10 | $157.68 | Total: $1,576.80 |
| 1 | 25 | $133.59 | Total: $3,339.75 |
| 1 | 50 | $113.88 | Total: $5,694.00 |
| 1 | 100 | $98.55 | Total: $9,855.00 |
Overview
Cindunistat (free base) is an orally available selective iNOS inhibitor for the study of arthritis.
Chemical Properties
| Molecular Formula | C8H17N3O2S |
| Molecular Weight | 219.3 |
| CAS Numbers | 364067-22-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | [C@](CSCCNC(C)=N)(C(O)=O)(C)N |
Storage and Handling
0C Short Term, -20C Long Term
References
Hellio le Graverand MP, et al. A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat [SD-6010], in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis. 2013 Feb;72[2] 187-95.